C08B 37/0078
Degradation products
Official title: {Degradation products}
C08B37/0078 (Degradation products) appears on 105 US grants and 109 published applications in this corpus.
Search patents in C08B- Granted patents
- 105
- Published applications
- 109
- Assignees
- 71
- Inventors
- 227
- Latest grant
- 1 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 6 | 0 |
| 1992 | 4 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 8 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 4 |
| 2003 | 4 | 2 |
| 2004 | 0 | 3 |
| 2005 | 2 | 14 |
| 2006 | 3 | 5 |
| 2007 | 0 | 6 |
| 2008 | 1 | 8 |
| 2009 | 3 | 5 |
| 2010 | 7 | 5 |
| 2011 | 6 | 8 |
| 2012 | 3 | 7 |
| 2013 | 8 | 4 |
| 2014 | 0 | 5 |
| 2015 | 5 | 4 |
| 2016 | 6 | 8 |
| 2017 | 1 | 1 |
| 2018 | 2 | 1 |
| 2019 | 2 | 2 |
| 2020 | 3 | 4 |
| 2021 | 1 | 5 |
| 2022 | 7 | 2 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of manufacturing a high molecular weight heparin compound1 Aug 2023US 11,712,447 B2NexEos Diagnostics, Inc.
- Process for the preparation of Dalteparin sodium8 Nov 2022US 11,492,421 B2Biological E Limited
- Carboxylated derivatives of glycosaminoglycans and use as drugs28 Jun 2022US 11,370,848 B2Novahealth Biosystems, LLC
- Carboxylated derivatives of glycosaminoglycans and use as drugs17 May 2022US 11,332,548 B2Novahealth Biosystems, LLC
- Expedient synthesis of core disaccharide building blocks from natural polysaccharides for heparan sulfate oligosaccharide assembly19 Apr 2022US 11,306,157 B2California Institute of Technology
- Ultralow molecular weight heparin13 Aug 2026US 2026/0234295 A1Beth Israel Deaconess Medical Center, Inc.
- Preparation of medium molecular weight heparin9 Jul 2026US 2026/0193385 A1Glycos Biomedical Ltd
- Methods for the chemoenzymatic synthesis of low molecular weight heparin from low molecular weight heparosan11 Jun 2026US 2026/0159866 A1Otsuka Pharmaceutical Factory, Inc.
- Synthetic hexasaccharides mimics of heparin showing heparanase inhibition activity1 Jan 2026US 2026/0001967 A1Centro Alta Tecnologia Istituto Di Ricerche Chimiche E Biochimiche G. Ronzoni S.R.L.
- Methods of manufacturing a high molecular weight heparin compound12 Oct 2023US 2023/0321137 A1NexEos Diagnostics, Inc.
Most cited
By later US patents
- Low molecular weight heparins of regular structure, their preparation and their biological uses.75US 4,990,502 ASanofi · 1991
- Composition comprising heparin as a non-thrombogenic surface coating agent68US 6,559,132 B1Carmeda AB · 2003
- Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation61US 5,380,716 AGlycomed Incorporated · 1995
- Process for the organic synthesis of oligosaccharides and derivatives thereof53US 4,818,816 AChoay S. A. · 1989
- Heparin fragments having selective anticoagulation activity41US 4,303,651 AAB Kabi · 1981